Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer
Status:
Terminated
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Study Objectives:
Primary objective
- The primary objective of this study is to investigate the combination of
cisplatin/gemcitabine/paclitaxel, with respect to complete remission in patients with
germ cell tumours previously treated with BEP.
Secondary Objectives
- Overall survival
- Progression free survival
- Response rates (RECIST)
- Duration of response
- To investigate the safety of paclitaxel, gemcitabine and cisplatin in patients
previously treated with BEP